Novartis Pharmaceuticals Corporation v. Apotex Inc. et al
| Novartis Pharmaceuticals Corporation |
| Bionpharma Inc., Strides Pharma, Inc., Prinston Pharmaceutical Inc., HEC Pharm USA Inc., Strides Global Pharma Private Limited, Emcure Pharmaceuticals, Heritage Pharmaceuticals Inc., Apotex Corp., Apotex Inc., Hetero Labs Limited, Glenmark Pharmaceuticals Limited, Glenmark Pharmaceuticals Inc., USA, HEC Pharm Co., Ltd., Zydus Pharmaceuticals (USA) Inc., Hetero USA Inc., Hetero Labs Limited Unit-V, Ezra Ventures, LLC and Cadila Healthcare Limited |
| 1:2020cv00133 |
| January 28, 2020 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 1 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 6, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 5
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (kmd)
|
|
Filing 4
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,543,179. (kmd)
|
|
Filing 3
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 12/25/2027. (kmd)
|
|
Filing 2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd)
|
|
Filing 1
COMPLAINT filed against Apotex Corp., Apotex Inc., Bionpharma Inc., Cadila Healthcare Limited, Emcure Pharmaceuticals, Ezra Ventures, LLC, Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited, HEC Pharm Co., Ltd., HEC Pharm USA Inc., Heritage Pharmaceuticals Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc., Prinston Pharmaceutical Inc., Strides Global Pharma Private Limited, Strides Pharma, Inc., Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number 0311-2837163.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibits A-B, #2 Civil Cover Sheet)(kmd)
|
|
No Summons Issued. (kmd)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
